Delivery Order SPE2DB22D2006-SPE2DB24FW1MW

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $10,210.12 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,565,133,949 units of the pharmaceutical product Valsartan-HCTZ 320-25 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a broad range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $5,202.62 to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of 4,565,057,934 units of the prescription medication Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which Amerisourcebergen holds with DLA Troop Support Medical to supply a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,943,211 units of Valsartan-HCTZ 320-12.5 mg tablets in packages of 90. The contract has a ceiling value of $10,255.95 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $6,894.05 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,062,501 units of Valsartan-HCTZ 320-12.5 mg tablets. The contract has an ultimate completion date of January 29, 2025. This contract is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,472.13 to AmerisourceBergen Drug Corp's Corporate Office division to provide VALSARTAN-HCTZ 160-12.5 MG TAB 90S pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure essential medical commodities, including...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp's Corporate Office Division a $4,590.37 firm-fixed-price delivery order contract (SPE2DX15D3108|SPE2DX24F27HA) for the supply of 90-count valsartan-hydrochlorothiazide 80-12.5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $1,236.13 firm fixed-price delivery order contract for 4565784415 Valsartan-HCTZ 160-12.5 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs and facilities...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,495.77 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VALSARTAN-HCTZ 80-12.5 MG TAB 90S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical and distribution company Amerisourcebergen Corporation. The $5,145.56 contract is for the delivery of the drug Valsartan-HCTZ 160-12.5 mg tablets to a location in Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,154,096 units of the drug Valsartan-HCTZ 160-12.5 mg tablets. The firm-fixed-price delivery order contract has a ceiling value of $4,156.30 and a completion date of December 21, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1MW
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $1,621.15 to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of 4,565,046,303 Valsartan-HCTZ 160-12.5 mg tablets. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/1/24, 5:12 PM